524394 Stock Overview
Vimta Labs Limited provides contract research and testing services in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Vimta Labs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹537.55 |
| 52 Week High | ₹621.40 |
| 52 Week Low | ₹288.90 |
| Beta | 0.66 |
| 1 Month Change | -10.77% |
| 3 Month Change | 34.54% |
| 1 Year Change | 55.88% |
| 3 Year Change | 375.50% |
| 5 Year Change | 102.39% |
| Change since IPO | 48,768.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524394 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -3.1% | -3.7% | -1.8% |
| 1Y | 55.9% | 8.3% | 13.1% |
Return vs Industry: 524394 exceeded the Indian Life Sciences industry which returned 8.3% over the past year.
Return vs Market: 524394 exceeded the Indian Market which returned 13.1% over the past year.
Price Volatility
| 524394 volatility | |
|---|---|
| 524394 Average Weekly Movement | 6.7% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in IN Market | 8.9% |
| 10% least volatile stocks in IN Market | 3.4% |
Stable Share Price: 524394 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 524394's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,368 | Harita Vasireddi | https://vimta.com |
Vimta Labs Limited provides contract research and testing services in India and internationally. It offers product discovery/development, post approval/marketing, preclinical/early development/study, clinical research and development, drug life cycle management support, bioanalytical, analytical, central lab, genetically modified organisms testing, clinical diagnostics, environment testing, preclinical research and testing, food testing and analytical development, and EMI/EMC testing services, as well as IND/505 (b)(2) enabling/studies; IVPT, IVRT, and IVBE studies; and testing services for dioxins and furans, trace heavy metals, label claims, radioactive isotopes, vitamins and minerals, packaging, and shelf life. The company provides solutions to agriculture, electricals and electronics, medical devices, speciality chemicals, biologics and biosimilars, environment, health and safety, nutraceuticals, water and beverages, crop care, food, packaging, clinical diagnostics, home and personal care, and pharmaceuticals industries.
Vimta Labs Limited Fundamentals Summary
| 524394 fundamental statistics | |
|---|---|
| Market Cap | ₹11.91b |
| Earnings (TTM) | ₹483.33m |
| Revenue (TTM) | ₹3.23b |
24.6x
P/E Ratio3.7x
P/S RatioIs 524394 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524394 income statement (TTM) | |
|---|---|
| Revenue | ₹3.23b |
| Cost of Revenue | ₹883.50m |
| Gross Profit | ₹2.35b |
| Other Expenses | ₹1.87b |
| Earnings | ₹483.33m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 14, 2023
| Earnings per share (EPS) | 21.82 |
| Gross Margin | 72.68% |
| Net Profit Margin | 14.95% |
| Debt/Equity Ratio | 5.3% |
How did 524394 perform over the long term?
See historical performance and comparison